BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9636152)

  • 41. Lymphoid Gene Upregulation on Circulating Progenitors Participates in Their T-Lineage Commitment.
    Zepponi V; Michaels Lopez V; Martinez-Cingolani C; Boudil A; Pasqualetto V; Skhiri L; Gautreau L; Legrand A; Megret J; Zavala F; Ezine S
    J Immunol; 2015 Jul; 195(1):156-65. PubMed ID: 26026063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases.
    Chuang E; Lee KM; Robbins MD; Duerr JM; Alegre ML; Hambor JE; Neveu MJ; Bluestone JA; Thompson CB
    J Immunol; 1999 Feb; 162(3):1270-7. PubMed ID: 9973379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developmental stage-specific effects of Pim-1 dysregulation on murine bone marrow B cell development.
    Xu Z; Gwin KA; Li Y; Medina KL
    BMC Immunol; 2016 Jun; 17(1):16. PubMed ID: 27287229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM; Cambier JC
    J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. src-family tyrosine kinase p55fgr is expressed in murine splenic B cells and is activated in response to antigen receptor cross-linking.
    Wechsler RJ; Monroe JG
    J Immunol; 1995 Apr; 154(7):3234-44. PubMed ID: 7897209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immature B lymphocytes are deficient in expression of the src-family kinases p59fyn and p55fgr1.
    Wechsler RJ; Monroe JG
    J Immunol; 1995 Feb; 154(4):1919-29. PubMed ID: 7836773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. B lineage-restricted rearrangement of a human Ig kappa transgene.
    Cavelier P; Nato F; Coquilleau I; Rolink A; Rougeon F; Goodhardt M
    Eur J Immunol; 1997 Jul; 27(7):1626-31. PubMed ID: 9247570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic mapping of the gene for a novel tyrosine kinase, Blk, to mouse chromosome 14.
    Kozak CA; Dymecki SM; Niederhuber JE; Desiderio SV
    Genomics; 1991 Apr; 9(4):762-4. PubMed ID: 2037301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
    Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
    Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
    Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
    Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD3-epsilon overexpressed in prothymocytes acts as an oncogene.
    Wang B; She J; Salio M; Allen D; Lacy E; Lonberg N; Terhorst C
    Mol Med; 1997 Jan; 3(1):72-81. PubMed ID: 9132282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. S-acylation of LCK protein tyrosine kinase is essential for its signalling function in T lymphocytes.
    Kabouridis PS; Magee AI; Ley SC
    EMBO J; 1997 Aug; 16(16):4983-98. PubMed ID: 9305640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Permissive roles of cytokines interleukin-7 and Flt3 ligand in mouse B-cell lineage commitment.
    von Muenchow L; Alberti-Servera L; Klein F; Capoferri G; Finke D; Ceredig R; Rolink A; Tsapogas P
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8122-E8130. PubMed ID: 27911806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BANK1 and BLK act through phospholipase C gamma 2 in B-cell signaling.
    Bernal-Quirós M; Wu YY; Alarcón-Riquelme ME; Castillejo-López C
    PLoS One; 2013; 8(3):e59842. PubMed ID: 23555801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of promising B lymphocyte kinase inhibitors using structure-guided virtual screening.
    Yang S; Wahab S; Almoyad MAA; Chen Y; Kalam N; Khalid M
    J Biomol Struct Dyn; 2023 Sep; ():1-11. PubMed ID: 37688373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple steps in the transformation of normal B cells towards neoplasia.
    Melchers F
    Curr Top Microbiol Immunol; 1984; 113():56-61. PubMed ID: 6332720
    [No Abstract]   [Full Text] [Related]  

  • 58. Transcriptomic analysis identifies B-lymphocyte kinase as a therapeutic target for desmoplastic small round cell tumor cancer stem cell-like cells.
    Magrath JW; Flinchum DA; Hartono AB; Sampath SS; O'Grady TM; Baddoo M; Haoyang L; Xu X; Flemington EK; Lee SB
    Oncogenesis; 2024 Jan; 13(1):2. PubMed ID: 38177125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BLK positively regulates TLR/IL-1R signaling by catalyzing TOLLIP phosphorylation.
    Li WW; Fan XX; Xu ZS; Zhu ZX; Zhu ZY; Cao XJ; Pei DS; Wang YZ; Zhang JY; Wang YY; Zheng HX
    J Cell Biol; 2024 Feb; 223(2):. PubMed ID: 38078859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tyrosine phosphorylation of IRF3 by BLK facilitates its sufficient activation and innate antiviral response.
    Li WW; Fan XX; Zhu ZX; Cao XJ; Zhu ZY; Pei DS; Wang YZ; Zhang JY; Wang YY; Zheng HX
    PLoS Pathog; 2023 Oct; 19(10):e1011742. PubMed ID: 37871014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.